The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients

CompletedOBSERVATIONAL
Enrollment

208

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

August 22, 2024

Study Completion Date

October 24, 2024

Conditions
Physical FunctionCancer, BreastLymphomaPatient EmpowermentPatient EducationQuality of Life
Interventions
OTHER

PRO Instruments assessment questionnaire

"Patient Reported Outcome (PRO) questionnaire consisting of:~* PRO-CTCAE (approximately 11 questions plus free text)~* Patient-Reported Outcomes Measurement Information System (PROMIS) physical function short form (version 8c) (8 questions)~* PRO ECOG question (1 question)~* EORTC Quality of Life questionnaire (QLQ)-F17 questions (17 questions)~* Functional Assessment of Cancer Therapy-General version, rated on a 5-point Likert scale, (FACT-GP5) (single item global side effect bother question) (1 question)~* The Patient Global Impression (PGI)-C and PGI-S items (anchors for physical function) (2 questions)"

OTHER

Baseline Survey Clinician- reported (ClinRO) ECOG

Baseline Survey completed prior to initiation of chemotherapy

DEVICE

Fitbit

wearable device

OTHER

"Hugo Health (Hugo)"

an electronic platform that aggregates real world EHR data with patient's wearable and PRO data

OTHER

6 Minute Walk Test (6MWT)

A comprehensive performance measure of exercise capacity, encompassing components of mobility, endurance, and functional capacity measure (PerfO)

Trial Locations (2)

55905

Mayo Clinic, Rochester

06511

Yale Cancer Center, New Haven

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Yale University

OTHER